Drug Shortage Report for XYLOCAINE 1% W EPINEPHRINE 1:100000
Report ID | 209382 |
Drug Identification Number | 00001791 |
Brand name | XYLOCAINE 1% W EPINEPHRINE 1:100000 |
Common or Proper name | lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE LIDOCAINE HYDROCHLORIDE |
Strength(s) | 0.01MG 10MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
Packaging size | 10 vials |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-01 |
Actual start date | |
Estimated end date | 2024-01-31 |
Actual end date | 2023-12-08 |
Shortage status | Avoided shortage |
Updated date | 2023-12-12 |
Company comments | VR44553CA1 XYLOCAIN AD 10MG:10MCG VIL 10X20ML |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-12-12 | French | Compare |
v3 | 2023-12-12 | English | Compare |
v2 | 2023-11-06 | French | Compare |
v1 | 2023-11-06 | English | Compare |
Showing 1 to 4 of 4